share_log

康弘药业:北京市通商(深圳)律师事务所关于成都康弘药业集团股份有限公司2022年股票增值权激励计划第二个行权期行权条件成就的法律意见书

Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the Achievement of the Enforcement Conditions for the Second Exercise Period of the 2022 Stock Value-added Rights Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.

SZSI ·  Oct 24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more